Liwei Zhao,1,2,* Ji Sun,2,* Kai Wang,3 Shengcheng Tai,2 Runmiao Hua,2 Yufu Yu,2 Yi Fan,1,2 Jiaguo Huang2 1Department of Urology, School of Medicine, Hangzhou Normal University, Hangzhou, 311121, Zhejiang Province, People’s Republic of China; 2Department of Urology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311202, Zhejiang Province, People’s Republic of China; 3Department of Urology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yi Fan; Jiaguo HuangDepartment of Urology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, No. 728 North...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cance...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
Jianfeng Cui,1,* Shouzhen Chen,1,* Qiyu Bo,2 Shiyu Wang,1 Ning Zhang,1 Meng Yu,1 Wenfu Wang,1 Jie Ha...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
Background: Bladder cancer is often prone to recurrence and metastasis. We sought to construct nomog...
Background: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC)...
6noIntroduction & Objectives: The aim of the study was to investigate the ability of the Controlling...
Background: Some risk classifications to determine prognosis of patients with non-muscle invasive bl...
Background:: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC...
Objective: We aimed to determine the validity of two risk scores for patients with non-muscle invasi...
BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...
Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...
textabstractObjective: We aimed to determine the validity of two risk scores for patients with non-m...
BACKGROUND: EORTC, CUETO and EAU are the most commonly used risk stratification models for recurrenc...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cance...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
Jianfeng Cui,1,* Shouzhen Chen,1,* Qiyu Bo,2 Shiyu Wang,1 Ning Zhang,1 Meng Yu,1 Wenfu Wang,1 Jie Ha...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
Background: Bladder cancer is often prone to recurrence and metastasis. We sought to construct nomog...
Background: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC)...
6noIntroduction & Objectives: The aim of the study was to investigate the ability of the Controlling...
Background: Some risk classifications to determine prognosis of patients with non-muscle invasive bl...
Background:: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC...
Objective: We aimed to determine the validity of two risk scores for patients with non-muscle invasi...
BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...
Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...
textabstractObjective: We aimed to determine the validity of two risk scores for patients with non-m...
BACKGROUND: EORTC, CUETO and EAU are the most commonly used risk stratification models for recurrenc...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cance...
BackgroundChemotherapy has been proven to bring survival benefit in patients with resected muscle-in...